(Q81405829)

English

Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination

scientific article published on 21 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Shu-Hsing Cheng

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jong-Dar Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Chih-Yin Hsiao

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Chih-Ching Chien

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ya-Chuan Yang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Hsiu-Hsing Hung

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Fang-Yeh Chu

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

21 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

8085-8090

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Chronic hepatitis B virus infection in Asian countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

A mass hepatitis B vaccination programme in Taiwan: its preparation, results and reasons for uncompleted vaccinations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Scheduling of revaccination against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Serial changes in titers of antibody to hepatitis B surface antigen after immunization of infants born to mothers with hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Long-term protection against carriage of hepatitis B virus after infant vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Immune response to hepatitis B revaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Twelve-year follow-up study of hepatitis B immunization of Senegalese infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.013

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.09.013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17920732%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81405829&oldid=2092166694"